The global hepatic cirrhosis market is expanding rapidly, fueled by increasing liver disease cases, advanced treatment options, and improved healthcare infrastructure. Conditions like hepatitis, ...
MedPage Today on MSN
GLP-1s and hepatic events; 'Shame, taboo, hygiene'; treating late-onset IBD
News and commentary from the world of gastroenterology and hepatology ...
The hepatic encephalopathy market is expected to witness steady growth over the coming years, driven by the rising prevalence of chronic liver diseases, cirrhosis, and alcohol-related liver disorders ...
The safety and efficacy of adebelimumab combined apatinib and hepatic artery infusion chemotherapy in the treatment of unresectable hepatocellular carcinoma: A retrospective study. This is an ASCO ...
MILAN — Fecal microbiota transplantation (FMT), also known as intestinal microbiota transplantation, significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with ...
In a clinical guideline issued by the American College of Gastroenterology and published in the March issue of the American Journal of Gastroenterology, recommendations are presented for the diagnosis ...
The common hepatic artery is one of the final branches of the celiac artery. It supplies oxygen-rich blood to the liver, pylorus, pancreas, and duodenum. It runs on the right inside the lesser sac, a ...
69 weeks (16 months) median hPFS in patients with uveal melanoma. 38 weeks (8.5 months) median hPFS in patients with cholangiocarcinoma. Importance of Repeated Treatments: The investigators’ approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results